U.S. onlyEducational navigation. Verify coverage and assistance with the official insurer, program, or treatment site.

How do I get Tzield through my insurance?

Tzield · teplizumab-mzwv · Reference/original anti-CD3 therapy

Tzield is part of the Teplizumab / Tzield family.

Provider-administered anti-CD3 therapy current FDA labeling includes Stage 2 type 1 diabetes and a 2026 Stage 3 pediatric indication; payer criteria may lag the label.

No account, member ID, name, date of birth or email is needed. Your selections stay in this page session.

1
WHY IS THIS MEDICINE BEING GIVEN?

Choose the diagnosis / reason.

Coverage rules can change by diagnosis and sometimes by formulation.

FINANCIAL HELP

Find help with your out-of-pocket costs.

Use the official support program below to check savings, patient-assistance, or access options that may apply to you.

TZIELD COMPASS Support Program →
IF COVERAGE GETS STUCK

The medicine may be only part of the problem.

Use the playbook that matches what is blocking treatment, then verify the current rule with the insurer, program or treatment site.

Build a next-step plan →

Important

MedicineCostHelp is an educational navigation tool, not an insurer and not a coverage determination. Medical policies, billing codes, product preferences and benefit placement can change. Sources were reviewed 2026-08-20. Verify the current official source before acting.

Search another expensive medicine →